The EU marketing authorization was withdrawn in July 2021. References
External links
"Moxetumomab pasudotox". Drug Information Portal. U.S. National Library of Medicine. "Moxetumomab Pasudotox-tdfk". National Cancer Institute. 24 October 2018. "Moxetumomab Pasudotox-tdfk". NCI Drug Dictionary. National Cancer Institute.
In these reports, 9 of the 15 patients were women (60%) with an average age of 25 years at diagnosis. In Kashmir, due to the use of a kanger which also causes kangri cancer. It is a classic finding in chronic pancreatitis and may also be seen in people with hypothyroidism or lymphedema

Pathogenesis
The pathogenesis of erythema ab igne remains unknown. It has been proposed that thermal radiation exposure can induce damage to superficial blood vessels that subsequently leads to epidermal vascular dilation. The dilation of vessels presents morphologically as the initially observed erythema. Red blood cell extravasation and deposition of hemosiderin that follows clinically appear as hyperpigmentation, which can occur in a reticular distribution. It has also been proposed that the distribution of affected blood vessels—predominantly in the superficial subcutaneous plexus (found in the papillary dermis)—results in the net-like pattern of erythema ab igne skin lesions. Diagnosis
Differential diagnosis
Livedo reticularis
Vasculitis

Treatment
Discontinuing contact with the heat source is the initial treatment of erythema ab igne. If the area is only mildly affected with slight redness, the condition may resolve after a few months. If the condition is severe and the skin pigmented and atrophic, then it is unlikely to resolve. In this case, there is a possibility that a squamous cell carcinoma or a neuroendocrine carcinoma such as a Merkel cell carcinoma may form. If there is a persistent sore that does not heal or a growing lump within the rash, a skin biopsy should be performed to rule out the possibility of skin cancer.